Published in Proc Natl Acad Sci U S A on March 05, 1996
Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J (1998) 3.83
Long QT syndrome: from channels to cardiac arrhythmias. J Clin Invest (2005) 2.71
Single-channel characteristics of wild-type IKs channels and channels formed with two minK mutants that cause long QT syndrome. J Gen Physiol (1998) 2.37
Zebrafish model for human long QT syndrome. Proc Natl Acad Sci U S A (2007) 2.13
Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J Clin Invest (2008) 1.93
Dominant negative guard cell K+ channel mutants reduce inward-rectifying K+ currents and light-induced stomatal opening in arabidopsis. Plant Physiol (2001) 1.82
KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc Natl Acad Sci U S A (1997) 1.70
Transcription factor MEF2A mutations in patients with coronary artery disease. Hum Mol Genet (2004) 1.65
Long QT and ventricular arrhythmias in transgenic mice expressing the N terminus and first transmembrane segment of a voltage-gated potassium channel. Proc Natl Acad Sci U S A (1998) 1.64
Weighing the evidence for a ternary protein complex mediating A-type K+ currents in neurons. J Physiol (2008) 1.64
Recurrent intrauterine fetal loss due to near absence of HERG: clinical and functional characterization of a homozygous nonsense HERG Q1070X mutation. Heart Rhythm (2008) 1.62
Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective. Heart Rhythm (2012) 1.62
Molecular ablation of ventricular tachycardia after myocardial infarction. Nat Med (2006) 1.54
Nonsense mutations in hERG cause a decrease in mutant mRNA transcripts by nonsense-mediated mRNA decay in human long-QT syndrome. Circulation (2007) 1.43
Mouse models of long QT syndrome. J Physiol (2006) 1.36
Mechanistic insight into human ether-à-go-go-related gene (hERG) K+ channel deactivation gating from the solution structure of the EAG domain. J Biol Chem (2010) 1.36
HERG channel (dys)function revealed by dynamic action potential clamp technique. Biophys J (2004) 1.20
Fever-induced QTc prolongation and ventricular arrhythmias in individuals with type 2 congenital long QT syndrome. J Clin Invest (2008) 1.18
Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias. Br J Clin Pharmacol (2010) 1.16
Human ether-à-go-go-related gene K+ channel gating probed with extracellular ca2+. Evidence for two distinct voltage sensors. J Gen Physiol (1999) 1.13
Hsp40 chaperones promote degradation of the HERG potassium channel. J Biol Chem (2009) 1.09
HERG1 channelopathies. Pflugers Arch (2009) 1.06
Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine. Br J Pharmacol (2002) 0.98
Unraveling monogenic channelopathies and their implications for complex polygenic disease. Am J Hum Genet (2003) 0.96
Food deprivation attenuates seizures through CaMKII and EAG K+ channels. PLoS Genet (2007) 0.95
T-wave morphology abnormalities in benign, potent, and arrhythmogenic I(kr) inhibition. Heart Rhythm (2011) 0.93
Robust L-type calcium current expression following heterozygous knockout of the Cav1.2 gene in adult mouse heart. J Physiol (2011) 0.92
Distinct gene-specific mechanisms of arrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1. Proc Natl Acad Sci U S A (2001) 0.91
Age-and sex-dependent mRNA expression of KCNQ1 and HERG in patients with long QT syndrome type 1 and 2. Arch Med Sci (2011) 0.91
Selective knockout of mouse ERG1 B potassium channel eliminates I(Kr) in adult ventricular myocytes and elicits episodes of abrupt sinus bradycardia. Mol Cell Biol (2003) 0.91
Intracellular potassium stabilizes human ether-à-go-go-related gene channels for export from endoplasmic reticulum. Mol Pharmacol (2009) 0.91
A splice site mutation in hERG leads to cryptic splicing in human long QT syndrome. J Mol Cell Cardiol (2008) 0.90
Rescue of protein expression defects may not be enough to abolish the pro-arrhythmic phenotype of long QT type 2 mutations. J Physiol (2016) 0.90
Enhancement of HERG K+ currents by Cd2+ destabilization of the inactivated state. Biophys J (1999) 0.89
Antiarrhythmics--from cell to clinic: past, present, and future. Heart (2000) 0.89
Retracted Concerted all-or-none subunit interactions mediate slow deactivation of human ether-à-go-go-related gene K+ channels. J Biol Chem (2014) 0.88
hERG1a N-terminal eag domain-containing polypeptides regulate homomeric hERG1b and heteromeric hERG1a/hERG1b channels: a possible mechanism for long QT syndrome. J Gen Physiol (2011) 0.88
Tuning of EAG K(+) channel inactivation: molecular determinants of amplification by mutations and a small molecule. J Gen Physiol (2012) 0.87
Genotype- and mutation site-specific QT adaptation during exercise, recovery, and postural changes in children with long-QT syndrome. Circ Arrhythm Electrophysiol (2011) 0.87
Genetics of channelopathies associated with sudden cardiac death. Glob Cardiol Sci Pract (2015) 0.87
Isoform-specific dominant-negative effects associated with hERG1 G628S mutation in long QT syndrome. PLoS One (2012) 0.86
Properties of WT and mutant hERG K(+) channels expressed in neonatal mouse cardiomyocytes. Am J Physiol Heart Circ Physiol (2010) 0.86
Stimulation of N-terminal truncated isoform of androgen receptor stabilizes human ether-á-go-go-related gene-encoded potassium channel protein via activation of extracellular signal regulated kinase 1/2. Endocrinology (2008) 0.85
Molecular Pathophysiology of Congenital Long QT Syndrome. Physiol Rev (2017) 0.85
Modulation of hERG channels by 5-(((1H-indazol-5-yl)oxy)methyl)-N-(4-(trifluoromethoxy)phenyl)pyrimidin-2-amine (ITP-2), a novel small molecule activator. Br J Pharmacol (2017) 0.84
Effects of TRH on heteromeric rat erg1a/1b K+ channels are dominated by the rerg1b subunit. J Physiol (2005) 0.84
Characterization of novel KCNH2 mutations in type 2 long QT syndrome manifesting as seizures. Can J Cardiol (2009) 0.84
Hypoxia inhibits maturation and trafficking of hERG K(+) channel protein: Role of Hsp90 and ROS. Biochem Biophys Res Commun (2009) 0.84
Proline scan of the HERG channel S6 helix reveals the location of the intracellular pore gate. Biophys J (2014) 0.83
Multiple splicing defects caused by hERG splice site mutation 2592+1G>A associated with long QT syndrome. Am J Physiol Heart Circ Physiol (2010) 0.82
The long QT syndrome. Indian Pacing Electrophysiol J (2002) 0.82
LQT2 nonsense mutations generate trafficking defective NH2-terminally truncated channels by the reinitiation of translation. Am J Physiol Heart Circ Physiol (2013) 0.82
Anesthetic drug midazolam inhibits cardiac human ether-à-go-go-related gene channels: mode of action. Drug Des Devel Ther (2015) 0.80
A new C-terminal hERG mutation A915fs+47X associated with symptomatic LQT2 and auditory-trigger syncope. Heart Rhythm (2008) 0.80
Cryo-EM Structure of the Open Human Ether-à-go-go-Related K(+) Channel hERG. Cell (2017) 0.80
Novel characteristics of a trafficking-defective G572R-hERG channel linked to hereditary long QT syndrome. Can J Cardiol (2010) 0.79
Proteomic analyses of transgenic LQT1 and LQT2 rabbit hearts elucidate an increase in expression and activity of energy producing enzymes. J Proteomics (2012) 0.79
Impaired cardiac sympathetic innervation in symptomatic patients with long QT syndrome. Eur J Nucl Med Mol Imaging (2011) 0.78
Identification of Kv11.1 isoform switch as a novel pathogenic mechanism of long-QT syndrome. Circ Cardiovasc Genet (2014) 0.78
Molecular mechanisms of inherited arrhythmias. Curr Genomics (2008) 0.78
A novel splice mutation of HERG in a Chinese family with long QT syndrome. J Zhejiang Univ Sci B (2005) 0.78
Eag Domains Regulate LQT Mutant hERG Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. PLoS One (2015) 0.78
Effects of cardiac sympathetic innervation on regional wall motion abnormality in patients with long QT syndrome. Heart (2000) 0.77
Blockade of permeation by potassium but normal gating of the G628S nonconducting hERG channel mutant. Biophys J (2011) 0.77
Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation. Br J Pharmacol (2014) 0.76
Mechanistic basis for type 2 long QT syndrome caused by KCNH2 mutations that disrupt conserved arginine residues in the voltage sensor. J Membr Biol (2013) 0.76
The phenotype/genotype relation and the current status of genetic screening in hypertrophic cardiomyopathy, Marfan syndrome, and the long QT syndrome. Heart (1997) 0.75
Association of the hERG mutation with long‑QT syndrome type 2, syncope and epilepsy. Mol Med Rep (2016) 0.75
Electrophysiological Characteristics of the LQT2 Syndrome Mutation KCNH2-G572S and Regulation by Accessory Protein KCNE2. Front Physiol (2016) 0.75
Cardiac Delayed Rectifier Potassium Channels in Health and Disease. Card Electrophysiol Clin (2016) 0.75
Your Father and Grandfather's Atrial Fibrillation: A Review of the Genetics of the Most Common Pathologic Cardiac Dysrhythmia. Curr Genomics (2015) 0.75
Congenital and drug-induced long-QT syndrome: an update. Neth Heart J (2004) 0.75
Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine. Pharmacol Res Perspect (2015) 0.75
Molecular pathogenesis of long QT syndrome type 2. J Arrhythm (2016) 0.75
Is long QT syndrome entering the era of molecular diagnosis? Heart (1997) 0.75
The interaction between delayed rectifier channel alpha-subunits does not involve hetero-tetramer formation. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.75
Impact of recent molecular studies on evaluation of ventricular arrhythmias. J Interv Card Electrophysiol (2000) 0.75
The "megaprimer" method of site-directed mutagenesis. Biotechniques (1990) 11.92
A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell (1995) 11.62
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell (1995) 10.18
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell (1995) 7.73
Determination of the subunit stoichiometry of a voltage-activated potassium channel. Nature (1991) 7.46
Mutations in the K+ channel signature sequence. Biophys J (1994) 6.81
Molecular mechanism for an inherited cardiac arrhythmia. Nature (1995) 6.09
Putative receptor for the cytoplasmic inactivation gate in the Shaker K+ channel. Nature (1991) 3.72
Specification of subunit assembly by the hydrophilic amino-terminal domain of the Shaker potassium channel. Science (1992) 3.53
Voltage-sensing residues in the S4 region of a mammalian K+ channel. Nature (1991) 3.01
Structural elements involved in specific K+ channel functions. Annu Rev Physiol (1992) 2.62
Alteration and restoration of K+ channel function by deletions at the N- and C-termini. Neuron (1990) 2.26
Incremental reductions of positive charge within the S4 region of a voltage-gated K+ channel result in corresponding decreases in gating charge. Neuron (1992) 2.09
Deletion analysis of K+ channel assembly. Neuron (1993) 1.91
A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell (1995) 11.62
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell (1995) 10.18
Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature (1996) 9.77
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell (1995) 7.73
Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation (2000) 7.50
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet (1996) 7.35
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26
MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell (1999) 5.49
Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nat Genet (1993) 5.09
Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation (1995) 4.48
Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet (1997) 3.90
Fast inactivation causes rectification of the IKr channel. J Gen Physiol (1996) 3.88
Elastin is an essential determinant of arterial morphogenesis. Nature (1998) 3.56
Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med (1998) 3.41
Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science (1998) 3.22
The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell (1993) 2.99
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation (2000) 2.95
A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet (1999) 2.88
Dedifferentiation of mammalian myotubes induced by msx1. Cell (2000) 2.72
Molecular basis of the long-QT syndrome associated with deafness. N Engl J Med (1997) 2.57
LIM-kinase1 hemizygosity implicated in impaired visuospatial constructive cognition. Cell (1996) 2.44
Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics (1996) 2.44
Novel arterial pathology in mice and humans hemizygous for elastin. J Clin Invest (1998) 2.41
Roles for Fgf signaling during zebrafish fin regeneration. Dev Biol (2000) 2.36
The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel. J Med Genet (2004) 2.33
Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet (1995) 2.30
Multiple mechanisms of Na+ channel--linked long-QT syndrome. Circ Res (1996) 2.29
Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides. Circ Res (1996) 2.05
Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1. Genomics (1998) 1.93
Long QT syndrome associated with syndactyly identified in females. Am J Cardiol (1995) 1.93
Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. Circulation (1996) 1.86
Impaired distal airway development in mice lacking elastin. Am J Respir Cell Mol Biol (2000) 1.82
Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation. J Biol Chem (1999) 1.82
Elastin point mutations cause an obstructive vascular disease, supravalvular aortic stenosis. Hum Mol Genet (1997) 1.77
Processing of the platelet-derived growth factor receptor. Biosynthetic and degradation studies using anti-receptor antibodies. J Biol Chem (1987) 1.76
Deletions of the elastin gene at 7q11.23 occur in approximately 90% of patients with Williams syndrome. Am J Hum Genet (1995) 1.68
Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet (1999) 1.57
Supravalvular aortic stenosis associated with a deletion disrupting the elastin gene. J Clin Invest (1994) 1.54
Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest (1996) 1.52
Induction of lef1 during zebrafish fin regeneration. Dev Dyn (2000) 1.48
A novel human gene, WSTF, is deleted in Williams syndrome. Genomics (1998) 1.47
Genome screen for QTLs contributing to normal variation in bone mineral density and osteoporosis. J Clin Endocrinol Metab (2000) 1.43
Assessment of polymorphism in zebrafish mapping strains. Genome Res (1999) 1.37
Mammalian myotube dedifferentiation induced by newt regeneration extract. Proc Natl Acad Sci U S A (2001) 1.37
Single HERG delayed rectifier K+ channels expressed in Xenopus oocytes. Am J Physiol (1997) 1.37
Long QT syndrome-associated mutations in the S4-S5 linker of KvLQT1 potassium channels modify gating and interaction with minK subunits. J Biol Chem (1999) 1.33
Platelet-derived growth factor receptors expressed by cDNA transfection couple to a diverse group of cellular responses associated with cell proliferation. J Biol Chem (1988) 1.31
Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel disease. Gut (2001) 1.23
Functional effects of mutations in KvLQT1 that cause long QT syndrome. J Cardiovasc Electrophysiol (1999) 1.23
A novel human gene FKBP6 is deleted in Williams syndrome. Genomics (1998) 1.21
Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11q12-13. J Bone Miner Res (1998) 1.18
ETL, a novel seven-transmembrane receptor that is developmentally regulated in the heart. ETL is a member of the secretin family and belongs to the epidermal growth factor-seven-transmembrane subfamily. J Biol Chem (2000) 1.10
Lidocaine-induced conduction disturbance in patients with systemic hyperkalemia. Ann Emerg Med (2000) 1.08
Relation between outer and luminal diameter in cannulated arteries. Am J Physiol (1999) 1.08
Complete physical map of the common deletion region in Williams syndrome and identification and characterization of three novel genes. Hum Genet (1998) 1.06
Platelet derived growth factor (PDGF) autocrine components in human tumor cell lines. J Neurooncol (1990) 0.92
Potassium channelopathies. Neuropharmacology (1997) 0.91
Long-QT syndrome-associated missense mutations in the pore helix of the HERG potassium channel. Circulation (2001) 0.90
Direct activation of an inwardly rectifying potassium channel by arachidonic acid. Mol Pharmacol (2001) 0.88
Molecular cloning, characterization, and genomic localization of a human potassium channel gene. Genomics (1992) 0.86
Dinucleotide repeat polymorphism at the KCNA5 locus. Hum Mol Genet (1993) 0.84
Analysis of single-nucleotide polymorphisms in the interleukin-4 receptor gene for association with inflammatory bowel disease. Immunogenetics (2000) 0.83
Hematological status and pregnancy outcomes. Am J Clin Nutr (1981) 0.83
Negative chemotaxis in cellular slime molds. J Bacteriol (1977) 0.82
George M. Cober Lecturer: Mark T. Keating. Molecular basis of the long-QT syndrome associated with deafness. Proc Assoc Am Physicians (1997) 0.77
Isolation of P1 insert ends by direct sequencing. Biotechniques (1994) 0.77
Genomic localization of the human gene for KCNA10, a cGMP-activated K channel. Genomics (1997) 0.75
Defining the molecular genetic basis of idiopathic dilated cardiomyopathy. Trends Cardiovasc Med (1997) 0.75
The stimulation of paracrine and autocrine mitogenic pathways by the platelet-derived growth factor receptor. J Cell Physiol Suppl (1987) 0.75
Molecular characterization and refined genomic localization of three human potassium ion channel genes. Cytogenet Cell Genet (1995) 0.75
The platelet-derived growth factor system. Cancer Treat Res (1989) 0.75
Signal transduction by the platelet-derived growth factor receptor. Cold Spring Harb Symp Quant Biol (1988) 0.75
Ablation strategies reflect evolving concepts of atrial fibrillation mechanisms. J Electrocardiol (2001) 0.75